Synthesis of Ganglioside GD3 and its Comparison with Bovine GD3 with Regard to Oligodendrocyte Apoptosis Mitochondrial Damage
Authors:
- Julio C.JCJulio C.
- Bernadett SimonBSBernadett Simon
- Oliver SpeerOSOliver Speer
- Marcel LeistMLMarcel Leist
- Richard R. SchmidtRSRichard R. Schmidt
- 18 May 2001
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 7 (10) , 2178-2184
Abstract
2,3‐Dehydroneuraminic acid derivative 5 was transformed in five efficient steps into sialyl donor 2, which has a phenylthio group on the β‐side of the 3‐position for anchimeric assistance and a diethyl phosphite residue as leaving group at the anomeric carbon. The known GM3 intermediate 10 was transformed into the 4b,4c,8c‐O‐unprotected acceptor 3, which was then allowed to react with 2 by using TMSOTf as catalyst and acetonitrile as solvent to afford the desired tetrasaccharide 12, which has an α(2–8)‐linkage between two neuraminic acid residues. Removal of the phenylthio group gave intermediate 13, which was transformed into O‐tetraosyl trichloroacetimidate 16 as glycosyl donor. Application of the azidosphingosine glycosylation procedure furnished GD3 (1) in high overall yield. Comparison of synthetic GD3 with bovine‐brain‐derived GD3 showed that there were similar effects in GD3‐triggered uncoupling of mitochondrial respiration and in induction of apoptosis in oligodendrocytes.Keywords
This publication has 36 references indexed in Scilit:
- Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activationThe FASEB Journal, 2000
- Lipid and Glycolipid Mediators in CD95-Induced Apoptotic Signaling1999
- 8-O-Sialylation of Neuraminic AcidJournal of the American Chemical Society, 1998
- Requirement for GD3 Ganglioside in CD95- and Ceramide-Induced ApoptosisScience, 1997
- Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosidesCancer Immunology, Immunotherapy, 1995
- Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatographyInternational Journal of Cancer, 1993
- Glycosphingolipids in the cerebrospinal fluid of patients with multiple sclerosisMolecular and Chemical Neuropathology, 1990
- Synthetic studies on cell-surface glycans. 65. Highly stereoselective synthesis of ganglioside GD3Journal of the American Chemical Society, 1989
- GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.Journal of Experimental Medicine, 1982
- Sialic Acids1982